Join to View Full Profile
975 Port Washington RdGrafton, WI 53024
Phone+1 262-329-5000
Fax+1 262-329-5205
Dr. Pao is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 1983 - 1987
Medical College of WisconsinClass of 1983
Certifications & Licensure
WI State Medical License 1989 - 2027
TN State Medical License 1987 - 1990
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
- CMS Meaningful Use Stage 1 Certification myAurora, Aurora Health Care, Inc., 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
Publications & Presentations
PubMed
- 52 citationsMolecular Characteristics Predict Clinical Outcomes: Prospective Trial Correlating Response to the EGFR Tyrosine Kinase Inhibitor Gefitinib with the Presence of Sensit...Naiyer A. Rizvi, Valerie W. Rusch, William Pao, Jamie E. Chaft, Marc Ladanyi
Clinical Cancer Research. 2011-05-15 - 473 citationsRebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based AssayMaria E. Arcila, Geoffrey R. Oxnard, Khedoudja Nafa, Gregory J. Riely, Stephen B. Solomon
Clinical Cancer Research. 2011-03-01 - 36 citationsMorphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.Maureen F. Zakowski, Sanaa Hussain, William Pao, Marc Ladanyi, Michelle S. Ginsberg
Archives of Pathology & Laboratory Medicine. 2009-10-01
Grant Support
- Overcoming Acquired Resistance To EGFR Inhibitors In Lung CancerNational Cancer Institute2009–2011
- EGFR Kinase Inhibitor-Persistent Egfr-Mutant Lung AdenocarcinomaNational Cancer Institute2007–2011
- Overcoming Acquired Resistance To EGFR Inhibitors In Lung CancerNational Cancer Institute2007–2008
- Elucidating Mechanisms Of Lung Tumor RegressionNational Cancer Institute2005–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
